Oxford University explores anti-parasitic drug ivermectin as COVID-19 treatment

Ivermectin resulted in a reduction of virus replication in laboratory studies, the university said, adding that a small pilot showed giving the drug early could reduce viral load and the duration of symptoms in some patients with mild COVID-19.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news